Bisoprolol 3.75mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Bisoprolol fumarate

Available from:

Alliance Healthcare (Distribution) Ltd

ATC code:

C07AB07

INN (International Name):

Bisoprolol fumarate

Dosage:

3.75mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 02040000

Patient Information leaflet

50 MM
15 MM
6 MM
19.5 MM
60.5 MM
PACKAGE LEAFLET: INFORMATION FOR THE USER
BISOPROLOL 1.25 MG FILM-COATED TABLETS
BISOPROLOL 2.5 MG FILM-COATED TABLETS
BISOPROLOL 3.75 MG FILM-COATED TABLETS
BISOPROLOL 5 MG FILM-COATED TABLETS
BISOPROLOL 7.5 MG FILM-COATED TABLETS
BISOPROLOL 10 MG FILM-COATED TABLETS
bisoprolol fumarate
Your medicine is called Bisoprolol 1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5
mg and 10 mg
film- coated tablets, but it will be referred to as Bisoprolol tablets
throughout this leaflet.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Bisoprolol tablets are and what they are used for
2.
What you need to know before you take Bisoprolol tablets
3.
How to take Bisoprolol tablets
4.
Possible side-effects
5.
How to store Bisoprolol tablets
6.
Contents of the pack and other information
1. WHAT BISOPROLOL TABLETS ARE AND WHAT THEY ARE USED FOR
Bisoprolol belongs to a group of medicines called beta-blockers. These
medicines work by
affecting the body's response to some nerve impulses, especially in
the heart.
As a result, bisoprolol slows down the heart rate and makes the heart
more efficient at
pumping blood around the body.
Heart failure occurs when the heart muscle is weak and unable to pump
enough blood to
supply the body's needs.
Bisoprolol is used to treat stable chronic heart failure. It is used
in combination with other
medicines suitable for this condition (such as ACE-inhibitors,
diuretics, and heart glycosides).
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE BISOPROLOL TABLETS
DO

Summary of Product characteristics

Page 1 of 14
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Bisoprolol 1.25 mg Film-coated tablets
Bisoprolol 2.5 mg Film-coated tablets
Bisoprolol 3.75 mg Film-coated tablets
Bisoprolol 5 mg Film-coated tablets
Bisoprolol 7.5 mg Film-coated tablets
Bisoprolol 10 mg Film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Bisoprolol 1.25mg: Each Film coated tablet contains 1.25mg Bisoprolol
Fumarate.
Bisoprolol 2.5mg: Each Film coated tablet contains 2.5mg Bisoprolol
Fumarate.
Bisoprolol 3.75mg: Each Film coated tablet contains 3.75mg Bisoprolol
Fumarate.
Bisoprolol 5mg: Each Film coated tablet contains 5mg Bisoprolol
Fumarate.
Bisoprolol 7.5mg: Each Film coated tablet contains 7.5mg Bisoprolol
Fumarate.
Bisoprolol 10mg: Each Film coated tablet contains 10mg Bisoprolol
Fumarate.
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Film-coated tablets
Bisoprolol 1.25mg: White coloured round, biconvex, film coated
tablets, plain on
both sides.
Bisoprolol 2.5mg: White and heart-shaped with a break-line on both
sides.
Bisoprolol 3.75mg: Off-white and heart-shaped with a break-line on
both sides.
Bisoprolol 5mg: White -yellow, heart-shaped with a break-line on both
sides
Bisoprolol 7.5mg: Pale yellow and heart-shaped with a break-line on
both sides.
Bisoprolol 10mg: Pale to light orange, heart-shaped with a break-line
on both
sides.
The tablets can be divided into equal doses.
Page 2 of 14
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of stable chronic heart failure with reduced systolic left
ventricular
function in addition to ACE inhibitors, and diuretics, and optionally
cardiac
glycosides (for additional information see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Standard treatment of CHF consists of an ACE inhibitor (or an
angiotensin receptor blocker in
case of intolerance to ACE inhibitors), a beta-blocker, diuretics, and
when appropriate cardiac
glycosides. Patients should be stable (without acute failure) when
bisoprolol treatment is
in